Takeda Pharmaceutical (TAK) Other Non-Current Liabilities: 2017-2025

Historic Other Non-Current Liabilities for Takeda Pharmaceutical (TAK) over the last 9 years, with Mar 2025 value amounting to $541.9 million.

  • Takeda Pharmaceutical's Other Non-Current Liabilities fell 0.94% to $541.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $541.0 million, marking a year-over-year decrease of 0.94%. This contributed to the annual value of $541.9 million for FY2025, which is 3.45% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Other Non-Current Liabilities of $541.9 million as of FY2025, which was down 3.45% from $561.2 million recorded in FY2024.
  • In the past 5 years, Takeda Pharmaceutical's Other Non-Current Liabilities registered a high of $561.2 million during FY2024, and its lowest value of $365.5 million during FY2021.
  • Over the past 3 years, Takeda Pharmaceutical's median Other Non-Current Liabilities value was $541.9 million (recorded in 2025), while the average stood at $505.8 million.
  • As far as peak fluctuations go, Takeda Pharmaceutical's Other Non-Current Liabilities dropped by 10.89% in 2023, and later surged by 35.47% in 2024.
  • Takeda Pharmaceutical's Other Non-Current Liabilities (Yearly) stood at $365.5 million in 2021, then increased by 27.20% to $464.9 million in 2022, then fell by 10.89% to $414.3 million in 2023, then surged by 35.47% to $561.2 million in 2024, then declined by 3.45% to $541.9 million in 2025.